News

New Intact Mass software application on waters_connect enables simplified and significantly faster analysis of biomolecules for mass and purity Intact Mass App is now available as an upgrade for ...
The firm’s oral macrocyclic peptides preserved lean muscle mass ... semaglutide in mice; rodents given the combo showed sustained weight loss compared to controls while keeping muscle intact ...
effectively counter-acting the lean mass loss associated with semaglutide-induced weight loss. These findings provide compelling evidence of the first-in-class potential of our oral peptide ...
who are overweight or have obesity and who are receiving WEGOVY (semaglutide), a GLP-1 receptor agonist (RA), for weight reduction. The primary endpoint was the change in total lean body mass from ...
"Combining HT-6184 with semaglutide enhances weight loss and preserves lean muscle mass—a crucial factor for overall metabolic health. These results bring us closer to a treatment that addresses ...
where there is growing evidence that myostatin inhibitors can preserve lean body mass in individuals living with obesity and taking a GLP-1 receptor agonist (such as semaglutide). To this end ...
In the topline efficacy analysis, the Phase 2b QUALITY clinical study met its primary endpoint with a statistically significant benefit in preservation of total lean body mass in all patients ...
Secondary endpoints showed: Enobosarm + semaglutide treatment resulted in a greater reduction in total fat mass compared to placebo + semaglutide at 16 weeks. There appears to be minor differences ...